NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NoorDx

NoorDx

Private
ThuwalHealthcare & Life Scienceshttps://www.noordx.sa/

Last Round

Series A

Mar 1, 2022

Total Funding Raised

$2.48M

Company Overview

NoorDx is a biotechnology company that provides clinical genomics, precision medicine, and genetic testing services to support healthcare and research in Saudi Arabia.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

genetic testinggenomic diagnosticsprecision medicinemolecular diagnosticsbioinformaticsclinical laboratoryreverse transcription polymerase chain reactionRT-PCRgenomic researchpreventative screeningbiotechclinical genomicsvariant callinggenomic data analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NoorDx Comparables

Compare NoorDx with similar companies based on industry and business-model similarity.

NoorDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anwa BioSciences
86%
Novo Genomics
86%
Enigma Genomics
83%

NoorDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 1, 2022
AcceleratorSep 17, 2018

NoorDx Investors

Notable investors and investment history

NoorDx investors
InvestorRounds
King Abdullah University of Science and Technology (KAUST)Accelerator
KAUST Innovation VenturesSeries A
TAQADAMAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Monthly visitors grew 114% MoM, reaching 5.8K.

  • Nov 7, 2025

    Monthly visitors grew 156% MoM, reaching 2.7K.

NoorDx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NoorDx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NoorDx's valuation, stock price, and market status.

Firmographic Details

HeadquartersThuwal
Employee Range7
Year Founded2017
Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.